ReviewWorld journal of clinical oncology2017
Current state and controversies in fertility preservation in women with breast cancer.
Review in World journal of clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Interventions for fertility preservation in women with cancer undergoing chemotherapy.The Cochrane database of systematic reviews · 2025Pooled it
- Fertility Preservation Practices at Pediatric Oncology Institutions in the United States: A Report From the Children's Oncology Group.JCO oncology practice · 2023Article
- Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study.Frontiers in oncology · 2022Article
- Senotherapy Protects against Cisplatin-Induced Ovarian Injury by Removing Senescent Cells and Alleviating DNA Damage.Oxidative medicine and cellular longevity · 2022Article
- Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation.Journal of assisted reproduction and genetics · 2021Article
- A review on the relationship between anti-mullerian hormone and fertility in treating young breast cancer patients.BMC women's health · 2021Review
- Cancer diagnosis in primary care: Six steps to reducing the diagnostic interval.Canadian family physician Medecin de famille canadien · 2021Article
- Article
- Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2021Review
- Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?Annals of surgical oncology · 2020Article
- The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.JBRA assisted reproduction · 2020Article
- Breast cancer: an update on treatment-related infertility.Journal of cancer research and clinical oncology · 2020Review
- Article
- Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.Clinical breast cancer · 2020Article
- Article
- Controversies Regarding Ovarian Suppression and Infertility in Early Stage Breast Cancer.Cancer management and research · 2020Review
- FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.Acta clinica Croatica · 2019Review
- Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis.Frontiers in pharmacology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On average, over 25000 women are diagnosed with breast cancer under the age of 45 annually in the United States. Because an increasing number of young women delay childbearing to later life for various reasons, a growing population of women experience breast cancer before completing childbearing. In this context, preservation of fertility potential of breast cancer survivors has become an essential concept in modern cancer care. In this review, we will outline the currently available fertility preservation options for women with breast cancer of reproductive age, discuss the controversy behind hormonal suppression for gonadal protection against chemotherapy and highlight the importance of timely referral by cancer care providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.